NCT04333082

Refractory Status Epilepticus Treatment: Quality and Efficacy of Coma Induction

Refractory Status Epilepticus Treatment (RESET): Quality and Efficacy of Coma Induction

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 147 (actual)
• Sponsor: University Hospital, Basel, Switzerland · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study is to investigate the effects of different treatment characteristics regarding the use of intravenous anesthetic drugs (IVADs) as a rescue treatment for refractory Status epilepticus (RSE) on course and outcome. A retrospective data extraction from the digital medical records, the electroencephalographic and microbiologic database of all consecutive adult patients with Status epilepticus (SE) admitted to the University Hospital Basel is undertaken.

Conditions

• Status Epilepticus
• Refractory Status Epilepticus

Interventions

Type	Name	Description
OTHER	Data collection	collection of patient data Data collection (demographics, prehospital management, duration of ICU and hospital stay, destination at discharge, date(s) of seizure(s), electroencephalographic (EEG) data, seizure history and etiology, number and duration of SE episodes, medication, types of SE according to the current guidelines from the International League of Epilepsy (ILAE), neuroimaging features, comorbidities, laboratory parameters, complications during and after SE , laboratory testing, vital signs, fluid balance) will be performed from the digital medical records, the electroencephalographic and microbiologic database of patients

Timeline

• Start date: 2020-04-22
• Primary completion: 2021-08-15
• Completion: 2022-08-03
• First posted: 2020-04-03
• Last updated: 2024-02-26

Locations

1 site across 1 country: Switzerland